
Sagility Reports Strong Q1 FY27 Results; Revenue Grows 27.6% YoY as Adjusted EBITDA Reaches 24.0%
Bengaluru, India | July 21, 2026 – Sagility Limited (NSE: SAGILITY, BSE: 544282), a global healthcare operations partner, announced its consolidated financial results for the quarter ended June 30, 2026. The company reported robust growth across key metrics, with revenue from operations reaching INR 19,634.83 million, representing a 27.6% increase year-over-year (YoY).The company showcased significant operational and strategic achievements during the quarter, including expanding its client base and strengthening its capabilities through an acquisition in the healthcare quality sector.
Financial Performance Highlights
Sagility's performance reflected healthy business momentum, with strong profitability figures reported across both consolidated and standalone results. Adjusted EBITDA for the quarter stood at INR 4,716 million (24.0% of revenue), marking a 27.9% YoY growth. Adjusted Profit After Tax (PAT) was recorded at INR 2,697 million (13.7% margin), achieving a substantial 35.1% YoY growth. Basic Earnings per share (EPS) stood at INR 0.46, up 45.9% YoY.The consolidated financial results for the quarter ended June 30, 2026, demonstrated stable revenue streams:
| Particulars | Quarter Ended June 30, 2026 (Unaudited) | Year Ended March 31, 2026 (Audited) |
|---|---|---|
| Revenue from Operations | INR 19,634.83 million | INR 71,928.51 million |
| Total Income | INR 19,778.06 million | INR 72,908.30 million |
| Total Expenses | INR 16,752.39 million | INR 60,191.08 million |
| Profit for the Period (Consolidated) | INR 2,168.11 million | INR 9,247.68 million |
Operational and Strategic Developments
Sagility continued its client expansion efforts in Q1 FY27, securing a steady-state ACV of $35.3 million through existing clients and new wins from the financial year ended 2026. The company added 27 new clients during the quarter, bringing its total active client base to 109.A key strategic move was the acquisition of CareSeed LLC, a U.S.-based healthcare technology company specializing in quality measurement (HEDIS) reporting and risk adjustment solutions. This acquisition is aimed at reinforcing Sagility's position in enhancing healthcare quality and expanding its reach in the Medicare Advantage and mid-market segments.
As of June 30, 2026, the Group reported having a presence in five countries with 29 delivery centers and employed 47,307 employees.
Management Commentary
Ramesh Gopalan, Managing Director and Group CEO, commented on the results, stating that healthcare organizations are increasingly seeking partners who combine expertise with technology, AI, and operational accountability to achieve measurable outcomes. He noted that the acquisition of CareSeed further solidifies Sagility’s capabilities in healthcare quality.Srinivas Mattapalli, Group Chief Financial Officer (CFO), added that the company started the year on a strong note, supported by resilient profitability and robust cash generation. He affirmed that Sagility remains well-positioned to invest in growth and drive long-term value for its stakeholders due to a strong balance sheet and healthy cash flows.
Exceptional Items
The consolidated financial results highlighted an exceptional item related to labor compliance costs. During the quarter ended June 30, 2026, a past service cost of ₹150.89 million was recognized in response to revised minimum wage rates notified by the state Governments of Karnataka and Telangana, as part of re-structuring compliant with the New Labour Codes.SAGILITY Stock Price Movement
Today, SAGILITY LIMITED rallied, closing at ₹41.84 after gaining ₹0.64, or 1.55%, in the post-market session. The stock saw a solid trading volume of 20.30 million shares today.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.